New Agents in the Treatment of Psychiatric Disorders: What Innovations and in What Areas of Psychopathology?
- Published in:
- Pharmaceuticals (14248247), 2025, v. 18, n. 5, p. 665, doi. 10.3390/ph18050665
- By:
- Publication type:
- Article
Works by Bozzatello, Paola
Results: 32
1
2
Gender differences in borderline personality disorder: a narrative review.
- Published in:
- Frontiers in Psychiatry, 2024, p. 1, doi. 10.3389/fpsyt.2024.1320546
- By:
- Publication type:
- Article
3
Conceptual disorganization as a mediating variable between visual learning and metacognition in schizophrenia.
- Published in:
- Frontiers in Psychiatry, 2024, p. 01, doi. 10.3389/fpsyt.2023.1278113
- By:
- Publication type:
- Article
4
Efficacy and Tolerability of Asenapine Compared with Olanzapine in Borderline Personality Disorder: An Open-Label Randomized Controlled Trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
5
Interpersonal Psychotherapy as a Single Treatment for Borderline Personality Disorder: A Pilot Randomized-Controlled Study.
- Published in:
- Frontiers in Psychiatry, 2020, v. 11, p. N.PAG, doi. 10.3389/fpsyt.2020.578910
- By:
- Publication type:
- Article
6
Effects on Satisfaction and Service Engagement of Paliperidone Palmitate Compared with Oral Paliperidone in Patients with Schizophrenia: An Open Label Randomized Controlled Trial.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 2, p. 169, doi. 10.1007/s40261-018-0734-1
- By:
- Publication type:
- Article
7
Combination of Omega-3 Fatty Acids and Valproic Acid in Treatment of Borderline Personality Disorder: A Follow-Up Study.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 4, p. 367, doi. 10.1007/s40261-017-0617-x
- By:
- Publication type:
- Article
8
Role of 3-monthly long-acting injectable paliperidone in the maintenance of schizophrenia.
- Published in:
- Neuropsychiatric Disease & Treatment, 2017, v. 13, p. 2767, doi. 10.2147/NDT.S150568
- By:
- Publication type:
- Article
9
Current and emerging medications for borderline personality disorder: is pharmacotherapy alone enough?
- Published in:
- Expert Opinion on Pharmacotherapy, 2020, v. 21, n. 1, p. 47, doi. 10.1080/14656566.2019.1686482
- By:
- Publication type:
- Article
10
Early Detection and Outcome in Borderline Personality Disorder.
- Published in:
- Frontiers in Psychiatry, 2019, p. 1, doi. 10.3389/fpsyt.2019.00710
- By:
- Publication type:
- Article
11
Predictive Factors of Treatment Resistance in First Episode of Psychosis: A Systematic Review.
- Published in:
- Frontiers in Psychiatry, 2019, p. N.PAG, doi. 10.3389/fpsyt.2019.00067
- By:
- Publication type:
- Article
12
Efficacy of omega-3 fatty acids in the treatment of borderline personality disorder: A study of the association with valproic acid.
- Published in:
- Journal of Psychopharmacology, 2014, v. 28, n. 2, p. 125, doi. 10.1177/0269881113510072
- By:
- Publication type:
- Article
13
The relative contributions of insight and neurocognition to intrinsic motivation in schizophrenia.
- Published in:
- Schizophrenia, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41537-022-00217-z
- By:
- Publication type:
- Article
14
Mental Health in Childhood and Adolescence: The Role of Polyunsaturated Fatty Acids.
- Published in:
- Biomedicines, 2021, v. 9, n. 8, p. 850, doi. 10.3390/biomedicines9080850
- By:
- Publication type:
- Article
15
Editorial: Borderline Personality Disorders in Adolescents: Clinical Challenges and Recent Advances.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
16
The Role of Trauma in Early Onset Borderline Personality Disorder: A Biopsychosocial Perspective.
- Published in:
- Frontiers in Psychiatry, 2021, v. 12, p. 1, doi. 10.3389/fpsyt.2021.721361
- By:
- Publication type:
- Article
17
Second Generation Long-Acting Injectable Antipsychotics in Schizophrenia: The Patient's Subjective Quality of Life, Well-Being, and Satisfaction.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 22, p. 6985, doi. 10.3390/jcm12226985
- By:
- Publication type:
- Article
18
The Role of Cognitive Deficits in Borderline Personality Disorder with Early Traumas: A Mediation Analysis.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 3, p. 787, doi. 10.3390/jcm12030787
- By:
- Publication type:
- Article
19
Real-World Functioning in Psychiatric Outpatients: Predictive Factors.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 15, p. 4400, doi. 10.3390/jcm11154400
- By:
- Publication type:
- Article
20
Efficacy of Serotonin and Dopamine Activity Modulators in the Treatment of Negative Symptoms in Schizophrenia: A Rapid Review.
- Published in:
- Biomedicines, 2023, v. 11, n. 3, p. 921, doi. 10.3390/biomedicines11030921
- By:
- Publication type:
- Article
21
The Impact of SARS-CoV-2 Infection on Youth Mental Health: A Narrative Review.
- Published in:
- Biomedicines, 2022, v. 10, n. 4, p. 772, doi. 10.3390/biomedicines10040772
- By:
- Publication type:
- Article
22
Paliperidone ER in the Treatment of Borderline Personality Disorder: A Pilot Study of Efficacy and Tolerability.
- Published in:
- Depression Research & Treatment, 2011, p. 1, doi. 10.1155/2011/680194
- By:
- Publication type:
- Article
23
Serotonin Transporter Gene: A New Polymorphism May Affect Response to Antidepressant Treatments in Major Depressive Disorder.
- Published in:
- Molecular Diagnosis & Therapy, 2014, v. 18, n. 5, p. 567, doi. 10.1007/s40291-014-0110-7
- By:
- Publication type:
- Article
24
Primary Psychosis: Risk and Protective Factors and Early Detection of the Onset.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 11, p. 2146, doi. 10.3390/diagnostics11112146
- By:
- Publication type:
- Article
25
Borderline Personality Disorder: Risk Factors and Early Detection.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 11, p. 2142, doi. 10.3390/diagnostics11112142
- By:
- Publication type:
- Article
26
Effectiveness of psychosocial treatments on symptoms and functional domains in schizophrenia spectrum disorders: a prospective study in a real-world setting.
- Published in:
- Disability & Rehabilitation, 2019, v. 41, n. 23, p. 2799, doi. 10.1080/09638288.2018.1480666
- By:
- Publication type:
- Article
27
Metabolic Dysfunctions, Dysregulation of the Autonomic Nervous System, and Echocardiographic Parameters in Borderline Personality Disorder: A Narrative Review.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 22, p. 12286, doi. 10.3390/ijms252212286
- By:
- Publication type:
- Article
28
Nutraceuticals in Psychiatric Disorders: A Systematic Review.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 9, p. 4824, doi. 10.3390/ijms25094824
- By:
- Publication type:
- Article
29
Efficacy of Polyunsaturated Fatty Acids (PUFAs) on Impulsive Behaviours and Aggressiveness in Psychiatric Disorders.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 2, p. 620, doi. 10.3390/ijms22020620
- By:
- Publication type:
- Article
30
Effects of Omega 3 Fatty Acids on Main Dimensions of Psychopathology.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 17, p. 6042, doi. 10.3390/ijms21176042
- By:
- Publication type:
- Article
31
Polyunsaturated Fatty Acids: What is Their Role in Treatment of Psychiatric Disorders?
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 21, p. 5257, doi. 10.3390/ijms20215257
- By:
- Publication type:
- Article
32
The Management of Prodromal Symptoms of Bipolar Disorder: Available Options and Future Perspectives.
- Published in:
- Medicina (1010660X), 2021, v. 57, n. 6, p. 1, doi. 10.3390/medicina57060545
- By:
- Publication type:
- Article